Development of a Colon Cancer GEMM-Derived Orthotopic Transplant Model for Drug Discovery and Validation
E. S. Martin(Tufts Medical Center), Kenneth E. Hung(Pfizer (United States)), Scott L. Weinrich(Pfizer (United States)), Mark J. Sinnamon(Tufts Medical Center), Zhihui Xie(China West Normal University), L. Lee(Tufts Medical Center), Sophia Y. Lunt(Michigan State University), Jing Yuan(Sun Yat-sen University), RamnikJ. Xavier(Tufts Medical Center), Roderick T. Bronson(Harvard University), Todd VanArsdale(Pfizer (United States)), Umar Mahmood(Athinoula A. Martinos Center for Biomedical Imaging), Tao Xie(Foshan University), Erin M. Coffee(Tufts Medical Center), Peter J. Belmont(Tufts Medical Center), John Lamb(Stockholm University), Jatin Roper(Duke University), Ji X(Tufts Medical Center), Julie L.C. Kan(Howard Hughes Medical Institute), Matthew G. Vander Heiden(Broad Institute), Gaurav Goel(Tufts Medical Center), Pedram Heidari(Massachusetts General Hospital)
Cited by 5
Related Papers
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
|Nature Biotechnology|1999|1.6k
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k
Telomere dysfunction induces metabolic and mitochondrial compromise
|Nature|2011|1.3k
Molecular Imaging
|Radiology|2001|1.3k
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
|Nature Genetics|2011|1.1k